<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2020-35-4-103-110</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-1080</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ И ОБЩЕСТВЕННОЕ ЗДОРОВЬЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HEALTHCARE AND PUBLIC HEALTH</subject></subj-group></article-categories><title-group><article-title>Применение информационной медицинской системы с целью быстрого скрининга сердечнососудистого риска у пациентов после коронарного стентирования</article-title><trans-title-group xml:lang="en"><trans-title>Medical information system for the rapid screening of cardiovascular risk in patients after coronary stenting</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1555-5725</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пушкарев</surname><given-names>Г. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pushkarev</surname><given-names>G. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пушкарев Георгий Сергеевич, канд. мед. наук, научный сотрудник, лаборатория инструментальной диагностики научного отдела инструментальных методов исследования</p><p>625026, Тюмень, ул. Мельникайте, 111</p></bio><bio xml:lang="en"><p>Georgiy S. Pushkarev, Cand. Sci. (Med.), Research Scientist, Laboratory of Instrumental Diagnostics, Scientifi c Division of Instrumental Research Methods </p><p>111, Melnikaite str., Tyumen, 625026</p></bio><email xlink:type="simple">Pushkarev@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1970-2606</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецов Вадим Анатольевич, д-р мед. наук, профессор, заслуженный деятель науки Российской Федерации, научный консультант</p><p>625026, Тюмень, ул. Мельникайте, 111</p></bio><bio xml:lang="en"><p>Vadim A. Kuznetsov, Dr. Sci. (Med.), Professor, Honored Scientist of the Russian Federation, Scientifi c Supervisor </p><p>111, Melnikaite str., Tyumen, 625026</p></bio><email xlink:type="simple">Kuznets@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8552-1646</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуськова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Guskova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гуськова Ольга Александровна, младший научный сотрудник, лаборатория инструментальной диагностики научного отдела инструментальных методов исследования</p><p>625026, Тюмень, ул. Мельникайте, 111</p></bio><bio xml:lang="en"><p>Olga A. Guskova, Junior Research Scientist, Laboratory of Instrumental Diagnostics, Scientifi c Division of Instrumental Research Methods </p><p>111, Melnikaite str., Tyumen, 625026</p></bio><email xlink:type="simple">Guskovaoa@infarkta.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1025-3728</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малишевский</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Malishevsky</surname><given-names>L. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малишевский Лев Михайлович, лаборант-исследователь, лаборатория инструментальной диагностики научного отдела инструментальных методов исследования</p><p>625026, Тюмень, ул. Мельникайте, 111</p></bio><bio xml:lang="en"><p>Lev M. Malishevsky, Laboratory Assistant, Laboratory of Instrumental Diagnostics, Scientifi c Division of Instrumental Research Methods </p><p>111, Melnikaite str., Tyumen, 625026</p></bio><email xlink:type="simple">Levmalishevskii@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Тюменский кардиологический научный центр, Томский национальный исследовательский медицинский центр Российской академии наук<country>Россия</country></aff><aff xml:lang="en">Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2020</year></pub-date><volume>35</volume><issue>4</issue><fpage>103</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пушкарев Г.С., Кузнецов В.А., Гуськова О.А., Малишевский Л.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Пушкарев Г.С., Кузнецов В.А., Гуськова О.А., Малишевский Л.М.</copyright-holder><copyright-holder xml:lang="en">Pushkarev G.S., Kuznetsov V.A., Guskova O.A., Malishevsky L.M.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/1080">https://www.sibjcem.ru/jour/article/view/1080</self-uri><abstract><sec><title>Цель</title><p>Цель: разработать и внедрить систему поддержки приятия решения для программного продукта – информационной медицинской системы «1С: Медицина» в виде калькулятора для определения абсолютного риска смерти от сердечно-сосудистых заболеваний (ССЗ), показать возможность использования этой системы для пациентов с ишемической болезнью сердца (ИБС), перенесших коронарное стентирование (КС).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В Тюменском кардиологическом научном центре Томского НИМЦ была разработана внешняя оболочка для программного продукта – информационной медицинской системы «1С: Медицина», предназначенная для определения 10-летнего абсолютного суммарного риска смерти от ССЗ у мужчин трудоспособного возраста (Тюменская шкала риска – ТШР) с целью поддержки принятия врачебных решений. Программа была апробирована на 764 пациентах мужского пола из «Проспективного регистра чрескожных коронарных вмешательств (ЧКВ)». Средний возраст пациентов составил 56,9 ± 8,8 года. В качестве переменной проверки состояния использовали все случаи смерти, зарегистрированные в течение одного года после проведения ЧКВ (n = 23). Для сравнения предсказывающей точности интегрированной модели были выбраны алгоритмы: PROCAM и FRAMINGHAM. Для оценки предсказывающей точности моделей использовали информационный критерий Шварца и данные ROC-анализа.</p></sec><sec><title>Результаты</title><p>Результаты. Критерий Шварца для ТШР у мужчин составил 283, для моделей PROCAM и FRAMINGHAM – 235 и 490 соответственно. Показатель AUC для ТШР составил 0,655 (95% ДИ 0,510–0,800), что свидетельствует об удовлетворительном качестве полученной модели. Показатель AUC для алгоритмов FRAMINGHAM и PROCAM составил 0,599 (95% ДИ 0,442–0,757) и 0,653 (95% ДИ 0,509–0,796) соответственно.</p></sec><sec><title>Выводы</title><p>Выводы. Созданная и интегрированная в информационную медицинскую информационную систему ТШР, включающая в себя психосоциальные факторы, может быстро и успешно применяться для определения вероятности наступления летального исхода у пациентов с ИБС в течение одного года после проведения КС, превосходит традиционную шкалу риска FRAMINGHAM и не уступает шкале PROCAM. Таким образом, ТШР может использоваться в качестве программы поддержки принятия врачебных решений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To develop and implement a decision support system for a software product – medical information system “1C: Medicine” in the form of calculator for assessment of the absolute risk of death from cardiovascular diseases (CVD) and to show the prospects of using this system for patients with coronary artery disease (CAD) after coronary stenting.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. The medical information system “1C: Medicine” software interface was developed in Tyumen Cardiology Research Center. It was designed to assess 10-year absolute total mortality risk from CVD in males of working age (Tyumen Risk Scale (TRS)) to provide medical decision support. The program was tested in 764 male patients from the Prospective Registry of Percutaneous Coronary Interventions (PCI). The mean age of patients was 56.9 ± 8.8 years. All death cases, recorded within a year after PCI (n = 23), were used as the status check variable. The following algorithms were chosen to compare the predictive accuracy of the integrated model: PROCAM and FRAMINGHAM. The Schwarz information test and ROC analysis data were used to assess the predictive accuracy of the models.</p></sec><sec><title>Results</title><p>Results. The values of Schwarz’s criterion in males were 283 for TRS, 235 for PROCAM, and 490 for FRAMINGHAM model. AUC indicator for TRS was 0.655 (95% CI 0.510–0.800), suggesting the satisfactory quality of resulting model. AUC indicators for FRAMINGHAM and PROCAM algorithms were 0.599 (95% CI 0.442–0.757) and 0.653 (95% CI 0.509–0.796), respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. The created TRS, integrated into the medical information system with psychosocial factors, may be quickly and successfully implemented to determine mortality risk in CAD patients within one year after coronary stenting. The TRS has an advantage over the traditional FRAMINGHAM risk scale and non-inferior to the PROCAM scale. Therefore, TRS may be used as a medical decision support program.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>факторы риска</kwd><kwd>суммарный сердечно-сосудистый риск</kwd><kwd>информационная медицинская система</kwd><kwd>цифровая медицина</kwd><kwd>коронарное стентирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>risk factors</kwd><kwd>total cardiovascular risk</kwd><kwd>medical information system</kwd><kwd>digital medicine</kwd><kwd>coronary stenting</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Coorey G.M., Neubeck L., Mulley J., Redfern J. Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data. Eur. J. Prev. Cardiol. 2018;25(5):505–521. DOI: 10.1177/2047487317750913.</mixed-citation><mixed-citation xml:lang="en">Coorey G.M., Neubeck L., Mulley J., Redfern J. Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data. Eur. J. Prev. Cardiol. 2018;25(5):505–521. DOI: 10.1177/2047487317750913.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yusuf S., Joseph P., Rangarajan S., Islam S., Mente A., Hystad P. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): А prospective cohort study. Lancet. 2020;395(10226):795–808. DOI: 10.1016/S0140-6736(19)32008-2.</mixed-citation><mixed-citation xml:lang="en">Yusuf S., Joseph P., Rangarajan S., Islam S., Mente A., Hystad P. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): А prospective cohort study. Lancet. 2020;395(10226):795–808. DOI: 10.1016/S0140-6736(19)32008-2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tamburrano A., Vallone D., Carrozza C., Urbani A., Sanguinetti M., Nicolotti N. et al. Evaluation and cost estimation of laboratory test overuse in 43 commonly ordered parameters through a Computerized Clinical Decision Support System (CCDSS) in a large university hospital. PLoS One. 2020;15(8):e0237159. DOI: 10.1371/journal.pone.0237159.</mixed-citation><mixed-citation xml:lang="en">Tamburrano A., Vallone D., Carrozza C., Urbani A., Sanguinetti M., Nicolotti N. et al. Evaluation and cost estimation of laboratory test overuse in 43 commonly ordered parameters through a Computerized Clinical Decision Support System (CCDSS) in a large university hospital. PLoS One. 2020;15(8):e0237159. DOI: 10.1371/journal.pone.0237159.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kharbanda E.O., Asche S.E., Sinaiko A.R., Ekstrom H.L., Nordin J.D., Sherwood N.E. et al. Clinical Decision Support for Recognition and Management of Hypertension: A Randomized Trial. Pediatrics. 2018;141(2):e20172954. DOI: 10.1542/peds.2017-2954.</mixed-citation><mixed-citation xml:lang="en">Kharbanda E.O., Asche S.E., Sinaiko A.R., Ekstrom H.L., Nordin J.D., Sherwood N.E. et al. Clinical Decision Support for Recognition and Management of Hypertension: A Randomized Trial. Pediatrics. 2018;141(2):e20172954. DOI: 10.1542/peds.2017-2954.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Patterson B.W., Pulia M.S., Ravi S., Hoonakker P.L.T., Hundt A.S., Wiegmann D. et al. Scope and Influence of Electronic Health Record-Integrated Clinical Decision Support in the Emergency Department: A Systematic Review. Ann. Emerg. Med. 2019;74(2):285–296. DOI: 10.1016/j.annemergmed.2018.10.034.</mixed-citation><mixed-citation xml:lang="en">Patterson B.W., Pulia M.S., Ravi S., Hoonakker P.L.T., Hundt A.S., Wiegmann D. et al. Scope and Influence of Electronic Health Record-Integrated Clinical Decision Support in the Emergency Department: A Systematic Review. Ann. Emerg. Med. 2019;74(2):285–296. DOI: 10.1016/j.annemergmed.2018.10.034.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Трубачева И.А., Пушкарев Г.С., Акимова Е.В., Кузнецов В.А., Солдатова А.М., Акимов А.М. Патент РФ № 2649829 С1. Способ определения 10-летнего абсолютного суммарного риска смерти от сердечно-сосудистых заболеваний у мужчин трудоспособного возраста. Опубл. 04.04.2018.</mixed-citation><mixed-citation xml:lang="en">Trubacheva I.A., Pushkarev G.S., Akimova E.V., Kuznetsov V.A., Soldatova A.M., Akimov A.M. Patent RF No. 2649829 С1. Method for determining the 10-year absolute total risk of death from cardiovascular diseases in men of working age. Publ. 04.04.2018 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Пушкарев Г.С., Кузнецов В.А., Акимова Е.В. Суммарный 10-летний риск смерти от сердечно-сосудистых заболеваний у мужчин 25–64 лет Тюмени. Профилактическая медицина. 2020;23(1):81–88. DOI: 10.17116/profmed20202301177.</mixed-citation><mixed-citation xml:lang="en">Pushkarev G.S., Kuznetsov V.A., Akimova E.V. Total 10-year risk of death from cardiovascular disease in 25–64 year-old men in Tyumen. The Russian Journal of Preventive Medicine and Public Health. 2020;23(1):81–88 (In Russ.). DOI: 10.17116/profmed20202301177.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310–315. DOI: 10.1161/hc0302.102575.</mixed-citation><mixed-citation xml:lang="en">Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310–315. DOI: 10.1161/hc0302.102575.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">D’Agostino R.B. Sr., Pencina M.J., Massaro J.M., Coady S. Cardiovascular disease risk assessment: Insights from Framingham. Glob. Heart. 2013;8(1):11–23. DOI: 10.1016/j.gheart.2013.01.001.</mixed-citation><mixed-citation xml:lang="en">D’Agostino R.B. Sr., Pencina M.J., Massaro J.M., Coady S. Cardiovascular disease risk assessment: Insights from Framingham. Glob. Heart. 2013;8(1):11–23. DOI: 10.1016/j.gheart.2013.01.001.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Neath A.A., Cavanaugh J.E. The Bayesian information criterion: background, derivation, and applications. WIREs Comp. Stat. 2012;4(2):199–203. DOI: 10.1002/wics.199.</mixed-citation><mixed-citation xml:lang="en">Neath A.A., Cavanaugh J.E. The Bayesian information criterion: background, derivation, and applications. WIREs Comp. Stat. 2012;4(2):199–203. DOI: 10.1002/wics.199.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hernández-Orallo J. ROC curves for regression. Pattern Recognition. 2013;46(12):3395–3411. DOI: 10.1016/j.patcog.2013.06.014.</mixed-citation><mixed-citation xml:lang="en">Hernández-Orallo J. ROC curves for regression. Pattern Recognition. 2013;46(12):3395–3411. DOI: 10.1016/j.patcog.2013.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Warraich H.J., Califf R.M., Krumholz H.M. The digital transformation of medicine can revitalize the patient-clinician relationship. NPJ Digit. Med. 2018;1:49. DOI: 10.1038/s41746-018-0060-2.</mixed-citation><mixed-citation xml:lang="en">Warraich H.J., Califf R.M., Krumholz H.M. The digital transformation of medicine can revitalize the patient-clinician relationship. NPJ Digit. Med. 2018;1:49. DOI: 10.1038/s41746-018-0060-2.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wongvibulsin S., Martin S.S., Steinhubl S.R., Muse E.D. Connected health technology for cardiovascular disease prevention and management. Curr. Treat. Options Cardiovasc. Med. 2019;21(6):29. DOI: 10.1007/s11936-019-0729-0.</mixed-citation><mixed-citation xml:lang="en">Wongvibulsin S., Martin S.S., Steinhubl S.R., Muse E.D. Connected health technology for cardiovascular disease prevention and management. Curr. Treat. Options Cardiovasc. Med. 2019;21(6):29. DOI: 10.1007/s11936-019-0729-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Screening for cardiovascular risk in asymptomatic patients. J. Am. Coll. Cardiol. 2010;55(12):1169–1177. DOI: 10.1016/j.jacc.2009.09.066.</mixed-citation><mixed-citation xml:lang="en">Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Screening for cardiovascular risk in asymptomatic patients. J. Am. Coll. Cardiol. 2010;55(12):1169–1177. DOI: 10.1016/j.jacc.2009.09.066.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamethee S.G., Shaper A.G., Lennon L., Morris R.W. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch. Intern. Med. 2005;165(22):2644–2650. DOI: 10.1001/archinte.165.22.2644.</mixed-citation><mixed-citation xml:lang="en">Wannamethee S.G., Shaper A.G., Lennon L., Morris R.W. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch. Intern. Med. 2005;165(22):2644–2650. DOI: 10.1001/archinte.165.22.2644.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Günaydın Z.Y., Karagöz A., Bektaş O., Kaya A., Kırış T., Erdoğan G. et al. Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. Anatol. J. Cardiol. 2016;16(6):412–418. DOI: 10.5152/AnatolJCardiol.2015.6317.</mixed-citation><mixed-citation xml:lang="en">Günaydın Z.Y., Karagöz A., Bektaş O., Kaya A., Kırış T., Erdoğan G. et al. Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. Anatol. J. Cardiol. 2016;16(6):412–418. DOI: 10.5152/AnatolJCardiol.2015.6317.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Versteylen M.O., Joosen I.A., Shaw L.J., Narula J., Hofstra L. Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J. Nucl. Cardiol. 2011;18(5):904–911. DOI: 10.1007/s12350-011-9425-5.</mixed-citation><mixed-citation xml:lang="en">Versteylen M.O., Joosen I.A., Shaw L.J., Narula J., Hofstra L. Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J. Nucl. Cardiol. 2011;18(5):904–911. DOI: 10.1007/s12350-011-9425-5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">D’Agostino R.B. Sr., Grundy S., Sullivan L.M., Wilson P.; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180–187. DOI: 10.1001/jama.286.2.180.</mixed-citation><mixed-citation xml:lang="en">D’Agostino R.B. Sr., Grundy S., Sullivan L.M., Wilson P.; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180–187. DOI: 10.1001/jama.286.2.180.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Brindle P., Beswick A., Fahey T., Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review. Heart. 2006;92(12):1752–1759.</mixed-citation><mixed-citation xml:lang="en">Brindle P., Beswick A., Fahey T., Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review. Heart. 2006;92(12):1752–1759.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper J.A., Miller G.J., Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005;181(1):93–100. DOI: 10.1016/j.atherosclerosis.2004.12.026.</mixed-citation><mixed-citation xml:lang="en">Cooper J.A., Miller G.J., Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005;181(1):93–100. DOI: 10.1016/j.atherosclerosis.2004.12.026.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Uthoff H., Staub D., Socrates T., Meyerhans A., Bundi B., Schmid H.P. et al. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis. Vasa. 2010;39(4):325–333. DOI: 10.1024/0301-1526/a000057.</mixed-citation><mixed-citation xml:lang="en">Uthoff H., Staub D., Socrates T., Meyerhans A., Bundi B., Schmid H.P. et al. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis. Vasa. 2010;39(4):325–333. DOI: 10.1024/0301-1526/a000057.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Woodward M., Brindle P., Tunstall-Pedoe H.; SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93(2):172–176. DOI: 10.1136/hrt.2006.108167.</mixed-citation><mixed-citation xml:lang="en">Woodward M., Brindle P., Tunstall-Pedoe H.; SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93(2):172–176. DOI: 10.1136/hrt.2006.108167.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: A validation study. Heart. 2008;94(1):34–39. DOI: 10.1136/hrt.2007.134890.</mixed-citation><mixed-citation xml:lang="en">Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: A validation study. Heart. 2008;94(1):34–39. DOI: 10.1136/hrt.2007.134890.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Трубачева И.А., Перминова О.А., Исаева Н.Н., Рудникович О.М. Патент РФ № 2 348 361 C1. Способ определения риска смерти от ишемической болезни сердца у мужчин, проживающих в условиях среднеурбанизированного города Западной Сибири. Опубл. 03.10.2009.</mixed-citation><mixed-citation xml:lang="en">Trubacheva I.A., Perminova O.A., Isaeva N.N., Rudnikovich O.M. Patent RF No. 2 348 361 C1. Method for evaluating ischemic heart disease death in men being residents moderately urbanized city of Western Siberia. Publ. 03.10.2009 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
